Homocysteine as a biomarker for cognitive dysfunction in the elderly

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 10, Issue 6, 2007, Pages 718-723

  Schulz, Ralf Joachim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cognitive dysfunction; Folic acid; Homocysteine; Marker; Vitamin B12

Indexed keywords

BIOLOGICAL MARKER; FOLIC ACID; HOMOCYSTEINE; HYDRALAZINE; ISONIAZID; PYRIDOXINE; THEOPHYLLINE; VITAMIN B GROUP;

ALZHEIMER DISEASE; BLOOD LEVEL; CLINICAL EVALUATION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; HOMOCYSTINURIA; HUMAN; MALNUTRITION; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; REVIEW;

AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MASS SCREENING; PREDICTIVE VALUE OF TESTS; VITAMIN B COMPLEX;

EID: 37349107157     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3282f0cfe3     Document Type: Review

References (75)

1. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56:111-128.
2. Stampfer MJ, Malinow MR, Willett WC. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992; 268:877-881.
3. Clarke R, Smith AD, Jobst KA, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55:1449-1455.
4. Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346:1395-1398.
5. Blom HJ. Determinants of plasma homocysteine. Am J Clin Nutr 1998; 67:188-189.
6. Eussen SJ, de Groot LC, Joosten LW, et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr 2006; 84:361-370.
7. Garcia A, Zanibbi K. Homocysteine and cognitive function in elderly people. CMAJ 2004; 171:897-904.
8. Rosenberg IH, Miller JW. Nutritional factors in physical and cognitive functions of elderly people. Am J Clin Nutr 1992; 55 (Suppl):1237S-1243S.
9. Lindenbaum J, Rosenberg IH, Wilson PW, et al. Prevalence of cobalamin deficiency in the Framinghamelderly population.AmJ ClinNutr1994;60:2-11.
10. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316:894-898.
11. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:2693-2698.
12. Garry PJ, Goodwin JS, Hunt WC. Folate and vitamin B12 status in a healthy elderly population. J Am Geriatr Soc 1984; 32:719-726.
13. Morris MS, Jacques PF, Rosenberg IH, Selhub J, National Health and Nutrition Examination Survey. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001; 73:927-933.
14. Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004; 50:3-32.
15. Luchsinger JA, Tang MX, Miller J, et al. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007; 64:86-92.
16. Stanger O, Herrmann W, Pietrzik K, et al. DACH-LIGA homocystein (German, Austrian and Swiss Homocysteine Society). Consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 2003; 41:1392-1403.
17. Lipton SA. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 1997; 94:5923-5928.
18. Nurk E, Tell GS, Nygard O, et al. Plasma total homocysteine is influenced by prandial status in humans: the Hordaland Homocysteine Study. J Nutr 2001; 131:1214-1216.
19. Metz J, Bell AH, Flicker L, Bottiglieri T. The significance of subnormal serum vitamin B12 concentration in older people: a case control study. J Am Geriatr Soc 1996; 44:1355-1361.
20. Ganji V, Kafai MR. Population reference values for plasma total homocysteine concentrations in US adults after the fortification of cereals with folic acid. Am J Clin Nutr 2006; 84:989-994.
21. Riggs KM, Spiro A 3rd, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996; 63:306-314.
22. La Rue A, Koehler KM, Wayne SJ, et al. Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr 1997; 65:20-29.
23. Raeder S, Landaas S, Laake K, et al. Homocysteine measurements in geriatric patients. Scand J Clin Lab Invest 2006; 66:309-315.
24. Duthie SJ, Whalley LJ, Collins AR, et al. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002; 75:908-913.
25. Andersson A, Brattstrom L, Israelsson B, et al. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992; 22:79-87.
26. Teunissen CE, Blom AH, Van Boxtel MP, et al. Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. J Nutr Health Aging 2003; 7:153-159.
27. Kalmijn S, Launer LJ, Lindemans J, et al. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol 1999; 150:283-289.
28. Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005; 82:636-643.
29. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
30. Chumlea WC, Guo S. Equations for predicting stature in white and black elderly individuals. J Gerontol 1992; 47:M197-M203.
31. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346:476-483.
32. Jacques PF, Bostom AG, Wilson PW, et al. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001; 73:613-621.
33. Fassbender K, Mielke O, Bertsch T, et al. Homocysteine in cerebral macro-angiography and microangiopathy. Lancet 1999; 353:1586-1587.
34. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338:1042-1050.
35. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986; 77:1370-1376.
36. Endo N, Nishiyama K, Okabe M, et al. Vitamin B6 suppresses apoptosis of NM-1 bovine endothelial cells induced by homocysteine and copper. Biochim Biophys Acta 2007; 1770:571-577.
37. Tsai JC, Wang H, Perrella MA, et al. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 1996; 97:146-153.
38. Mooijaart SP, Gussekloo J, Frolich M, et al. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study. Am J Clin Nutr 2005; 82:866-871.
39. Robbins MA, Elias MF, Budge MM, et al. Homocysteine, type 2 diabetes mellitus, and cognitive performance: the Maine-Syracuse Study. Clin Chem Lab Med 2005; 43:1101-1106.
40. Eussen SJ, Ueland PM, Clarke R, et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. Br J Nutr 2007; 31 May [Epub ahead of print].
41. Kruman II, Culmsee C, Chan SL, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000; 20:6920-6926.
42. Zhang D, Lipton SA. L-homocysteic acid selectively activates N-methyl-D-aspartate receptors of rat retinal ganglion cells. Neurosci Lett 1992; 139:173-177.
43. Rowan EN, Dickinson HO, Stephens S, et al. Homocysteine and poststroke cognitive decline. Age Ageing 2007; 36:339-343.
44. Huang RF, Huang SM, Lin BS, et al. Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci 2001; 68:2799-2811.
45. Ho PI, Ortiz D, Rogers E, Shea TB. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 2002; 70:694-702.
46. Ellinson M, Thomas J, Patterson A. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Dietet 2004; 17:317-383.
47. Crystal HA, Ortof E, Frishman WH, et al. Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1994; 42:933-936.
48. Hin H, Clarke R, Sherliker P, et al. Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 study. Age Ageing 2006; 35:416-422.
49. Wahlin A, Hill RD, Winblad B, Backman L. Effects of serum vitamin B12 and folate status on episodic memory performance in very old age: a population-based study. Psychol Aging 1996; 11:487-496.
50. Jacques PF, Rosenberg IH, Rogers G. Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999; 69:482-489.
51. Lindenbaum J, Healton EB, Savage DG. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis: 1988. Nutrition 1995; 11:181.
52. Saw SM, Yuan JM, Ong CN, et al. Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. Am J Clin Nutr 2001; 73:232-239.
53. McCaddon A, Hudson P, Hill D, et al. Alzheimer's disease and total plasma aminothiols. Biol Psychiatry 2003; 53:254-260.
54. Ikeda T, Furukawa Y, Mashimoto S, et al. Vitamin B12 levels in serum and cerebrospinal fluid of people with Alzheimer's disease. Acta Psychiatr Scand 1990; 82:327-329.
55. Fioravanti M, Ferrario E, Massaia M, et al. Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr 1997; 26:1-13.
56. Quadri P, Fragiacomo C, Pezzati R, et al. Homocysteine and B vitamins in mild cognitive impairment and dementia. Clin Chem Lab Med 2005; 43:1096-1100.
57. Miller AL. The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev 2003; 8:7-19.
58. Dufouil C, Alpérovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003; 53:214-221.
59. Tucker KL, Qiao N, Scott T, et al. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005; 82:627-635.
60. Connelly PJ, Prentice NP, Cousland G, Bonham J. A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. Int J Geriatr Psychiatry 2007; 29 June [Epub ahead of print].
61. Budge M, Johnston C, Hogervorst E. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann N Y Acad Sci 2000; 903:407-410.
62. Ramos MI, Allen LH, Mungas DM, et al. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2005; 82:1346-1352.
63. Kado DM, Karlamangla AS, Huang MH, et al. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 2005; 118:161-167.
64. Snowdon DA, Tully CL, Smith CD, et al. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr 2000; 71:993-998.
65. Garcia A, Haron Y, Pulman K, et al. Increases in homocysteine are related to worsening of Stroop scores in healthy elderly persons: a prospective follow-up study. J Gerontol A Biol Sci Med Sci 2004; 59:1323-1327.
66. Wang HX, Wahlin A, Basun H, et al. Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology 2001; 56:1188-1194.
67. Morris MC, Evans DA, Schneider JA, et al. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. J Alzheimers Dis 2006; 9:435-443.
68. Malouf M, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev 2003; (4):CD004514.
69. Clarke R, Harrison G, Richards S, Vital Trial Collaborative Group. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med 2003; 254:67-75.
70. McMahon JA, Green TJ, Skeaff CM, et al. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006; 354:2764-2772.
71. Bryan J, Calvaresi E, Hughes DJ. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. Nutr 2002; 132:1345-1356.
72. Durga J, van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007; 369:208-216. Well organized clinical study with healthy volunteers in a region where general folic acid fortification is not performed.
73. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J 1993; 7:1344-1353.
74. Chanarin I, Metz J. Diagnosis of cobalamin deficiency: the old and the new. Br J Haematol 1997; 97:695-700.
75. Stabler SP, Marcell PD, Podell ER, et al. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 1988; 81:466-474.